ArticleBMC cancer2025
Assessing the risk of undetected cervical cancer in women with a biopsy of high-grade cervical intraepithelial neoplasia: predictive value of cytology and endocervical curettage (ECC).
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify risk factors for a final diagnosis of cervical cancer in patients initially diagnosed with high-grade cervical intraepithelial neoplasia and to evaluate a combined Cytology-Endocervical Curettage (ECC) index for predicting cancer risk.
methodsThis retrospective study included 11,651 patients at West China Second University Hospital (WCSUH) with biopsy-confirmed high-grade cervical intraepithelial neoplasia over a five-year period. Patients were divided into two groups based on whether they ultimately received a diagnosis of cervical cancer following surgery. Multivariate logistic regression was used to identify independent risk factors, and receiver operating characteristic (ROC) curves were constructed to assess the performance of the Cytology-ECC index.
resultsOf the 11,651 patients, 229 were subsequently diagnosed with cervical cancer. Multivariate analysis identified age (OR = 1.10, 95% CI: 1.06-1.14), abnormal vaginal bleeding (OR = 2.94, 95% CI: 1.75-4.92), human papillomavirus (HPV)16/18 infection (OR = 2.56, 95% CI: 1.62-4.03), single HPV type infection (OR = 1.68, 95% CI: 1.03-2.75), atypical squamous cells, cannot exclude HSIL (ASC-H) (OR = 3.77, 95% CI: 1.68-8.45), high-grade squamous intraepithelial lesion (HSIL) (OR = 4.65, 95% CI: 2.16-10.05), and endocervical glandular involvement (OR = 1.59, 95% CI: 1.01-2.49) as independent risk factors (all P < 0.05). The Cytology-ECC index demonstrated a predictive accuracy with an area under the curve (AUC) of 0.787, outperforming cytology or ECC alone.
conclusionsAge, abnormal vaginal bleeding, HPV16/18, single HPV type infection, ASC-H, HSIL, and endocervical glandular involvement were independent predictors of cervical cancer in patients with an initial biopsy of high-grade cervical intraepithelial neoplasia. The combined Cytology-ECC index showed enhanced predictive value in clinical decision-making and may aid in earlier identification of patients at elevated risk for undetected invasive disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.